Veru
VERU
$1.64
Share price
10.07%
Change (1 day)
22.39%
Change (1 year)
Categories
P/S ratio for Veru (VERU)
P/S ratio as of May 2024 (TTM): 13.7
According to Veru's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13.6917. At the end of 2023 the company had a P/S ratio of 6.61.
P/S ratio history for Veru from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 6.61 | -56.93% |
| 2022 | 15.4 | 97.96% |
| 2021 | 7.76 | -40.34% |
| 2020 | 13.0 | 114.84% |
| 2019 | 6.05 | 35.62% |
| 2018 | 4.46 | -4.94% |
| 2017 | 4.69 | 182.08% |
| 2016 | 1.66 | 35.11% |
| 2015 | 1.23 | -73.34% |
| 2014 | 4.62 | -46.59% |
| 2013 | 8.65 | 52.52% |
| 2012 | 5.67 | 6.19% |
| 2011 | 5.34 | -30.42% |
| 2010 | 7.67 | 69.06% |
| 2009 | 4.54 | 18.9% |
| 2008 | 3.82 | 14.22% |
| 2007 | 3.34 | 38.24% |
| 2006 | 2.42 | -22.36% |
| 2005 | 3.11 | -45.73% |
| 2004 | 5.74 | -2.8% |
| 2003 | 5.90 | 81.19% |
| 2002 | 3.26 | 94.76% |
| 2001 | 1.67 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.03 | -92.51% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 575.58% | 🇺🇸 USA |